Tripathy, D, Tolaney, S, Seidman, AD et al. (5 more authors) (2017) Phase 3 study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer who have stable brain metastases previously treated with an anthracycline, a taxane, and capecitabine. In: Cancer Research. 2016 San Antonio Breast Cancer Symposium, 06 Dec 2016 - 10 Dec 2010, San Antonio, Texas, U.S.A.. American Association for Cancer Research .
Metadata
| Authors/Creators: |
|
|---|---|
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 11 Jul 2019 13:59 |
| Last Modified: | 11 Jul 2019 15:01 |
| Status: | Published |
| Publisher: | American Association for Cancer Research |
| Identification Number: | https://doi.org/10.1158/1538-7445.SABCS16-OT1-04-08 |
| Related URLs: |
Download not available
A full text copy of this item is not currently available from White Rose Research Online
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)